Rubicon Founders LLC has significantly increased its stake in Privia Health Group (NASDAQ: PRVA), purchasing 175,142 shares valued at approximately $3.95 million. This move brings Rubicon’s total holdings in Privia to 5,948,664 shares, making up nearly 89% of the fund’s reportable assets under management (AUM). The transaction reflects a bullish sentiment towards Privia, despite the stock’s recent decline of 4.4% over the past year.
This concentrated position in Privia is notable as it underscores the hedge fund’s confidence in the company’s growth trajectory. Privia reported impressive financials for 2025, with revenues of $2.1 billion, a 22% increase year-over-year, and a net income rise of 59%. The company continues to expand its revenue base, projecting full-year revenues of around $2.4 billion for 2026, signaling strong demand for its healthcare solutions.
For investors, Rubicon’s substantial investment could indicate a long-term opportunity in Privia Health Group, particularly given its solid fundamentals and growth prospects. However, with such a high concentration of AUM in a single stock, potential investors should weigh the risks associated with this level of dependence on Privia’s performance.
Source: nasdaq.com